{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:02:48Z","timestamp":1793714568808,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment is common in multiple sclerosis (MS), yet comprehensive cognitive assessment is not universally accessible, and patients need to be triaged for referral. Given the links between brain atrophy and cognition, this study investigated whether routinely collected neuroimaging markers could identify MS patients at risk of cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were retrospectively analysed from adult MS patients assessed in a specialist cognitive neuroimmunology clinic, who had undergone MRI within 12 months prior to cognitive testing. Normalised brain volume (NBV), normalised grey matter volume (NGMV), normalised white matter volume (NWMV), and corpus callosum index (CCI) were measured using the Siemens MorphoBox automated software. GLMs were estimated to investigate group differences in brain volume metrics between cognitively impaired and non-impaired patients. ROC curves were estimated to investigate screening performance for neuroimaging metrics (Youden\u2019s J). Results are expressed as parameter estimates with 95% bootstrapped confidence intervals (CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      120 patients were included (35% cognitively impaired). Cognitively impaired patients had lower NBV (\n                      <jats:italic>b<\/jats:italic>\n                      \u2009=\u2009\u2212\u20092.06, 95% CI [\u2212\u20093.35, \u2212\u20090.81]) and NWMV (\n                      <jats:italic>b<\/jats:italic>\n                      \u2009=\u2009\u2212\u20091.65, 95% CI [\u2212\u20092.60, \u2212\u20090.77]). NWMV (area under the curve [AUC] = 0.67, 95% CI [0.57, 0.76]) and CCI (AUC = 0.62, 95% CI [0.51, 0.72]) classified impairment, although sensitivity was low (&lt;\u20090.70). No clear associations or sufficient classification performance were observed for NGMV. Diagnostic performance improved when neuroimaging markers were statistically combined with relevant demographic information.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The present study did not find strong evidence supporting routinely collected neuroimaging as standalone cognitive screening tools. Classification performance improved when combined with demographic factors, but remained below thresholds for clinical utility. These findings highlight a gap between group-level associations reported in the literature and their translation to individual-level clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-05085-z","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:13:14Z","timestamp":1781709194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-7939","authenticated-orcid":false,"given":"Reine E.","family":"Jardine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4413-5359","authenticated-orcid":false,"given":"Valeriya","family":"Kuznetsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9657-2999","authenticated-orcid":false,"given":"Fiore","family":"D\u2019Aprano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-1376","authenticated-orcid":false,"given":"Tomas","family":"Kalinicik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8969-7577","authenticated-orcid":false,"given":"Stefanie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-3718","authenticated-orcid":false,"given":"Charles B.","family":"Malpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"5085_CR1","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","volume":"7","author":"ND Chiaravalloti","year":"2008","unstructured":"Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol Elsevier. 2008;7:1139\u201351. https:\/\/doi.org\/10.1016\/S1474-4422(08)70259-X.","journal-title":"Lancet Neurol Elsevier"},{"key":"5085_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11065-024-09640-8","volume":"35","author":"W Wu","year":"2025","unstructured":"Wu W, Francis H, Lucien A, Wheeler T-A, Gandy M. The Prevalence of Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-analysis. Neuropsychol Rev. 2025;35:233\u201353. https:\/\/doi.org\/10.1007\/s11065-024-09640-8.","journal-title":"Neuropsychol Rev"},{"key":"5085_CR3","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1007\/s00415-024-12254-y","volume":"271","author":"VR Ferreira","year":"2024","unstructured":"Ferreira VR, Brayne C, Ragonese P, Ketzoian C, Piccioli M, Tinti L, et al. A Delphi consensus to identify the key screening tests\/questions for a digital neurological examination for epidemiological research. J Neurol. 2024;271:2694\u2013703. https:\/\/doi.org\/10.1007\/s00415-024-12254-y.","journal-title":"J Neurol"},{"key":"5085_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000004977","volume":"90","author":"JF Sumowski","year":"2018","unstructured":"Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, et al. Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology. 2018;90:278\u201388. https:\/\/doi.org\/10.1212\/WNL.0000000000004977.","journal-title":"Neurology"},{"key":"5085_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/S1474-4422(20)30277-5","volume":"19","author":"RHB Benedict","year":"2020","unstructured":"Benedict RHB, Amato MP, DeLuca J, Geurts JJG. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. Lancet Neurol Elsevier. 2020;19:860\u201371. https:\/\/doi.org\/10.1016\/S1474-4422(20)30277-5.","journal-title":"Lancet Neurol Elsevier"},{"key":"5085_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/WCO.0000000000001481","volume":"39","author":"E De Meo","year":"2026","unstructured":"De Meo E, Portaccio E, Amato MP. Cognition in multiple sclerosis. Curr Opin Neurol. 2026;39:247. https:\/\/doi.org\/10.1097\/WCO.0000000000001481.","journal-title":"Curr Opin Neurol"},{"key":"5085_CR7","doi-asserted-by":"publisher","unstructured":"Skorve E, Lundervold AJ, Torkildsen \u00d8, Riemer F, Gr\u00fcner R, Myhr K-M. Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS \u2013 A longitudinal correlation study. Mult Scler Relat Disord. Elsevier; 2023 [cited 2026 Mar 11];69. https:\/\/doi.org\/10.1016\/j.msard.2022.104398","DOI":"10.1016\/j.msard.2022.104398"},{"key":"5085_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S1474-4422(06)70349-0","volume":"5","author":"RA Bermel","year":"2006","unstructured":"Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol Elsevier. 2006;5:158\u201370. https:\/\/doi.org\/10.1016\/S1474-4422(06)70349-0.","journal-title":"Lancet Neurol Elsevier"},{"key":"5085_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jns.2018.01.011","volume":"386","author":"G Fenu","year":"2018","unstructured":"Fenu G, Lorefice L, Arru M, Sechi V, Loi L, Contu F, et al. Cognition in multiple sclerosis: Between cognitive reserve and brain volume. J Neurol Sci Elsevier. 2018;386:19\u201322. https:\/\/doi.org\/10.1016\/j.jns.2018.01.011.","journal-title":"J Neurol Sci Elsevier"},{"key":"5085_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/jon.12237","volume":"25","author":"T Granberg","year":"2015","unstructured":"Granberg T, Bergendal G, Shams S, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S, et al. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index. J Neuroimaging. 2015;25:996\u20131001. https:\/\/doi.org\/10.1111\/jon.12237.","journal-title":"J Neuroimaging"},{"key":"5085_CR11","doi-asserted-by":"publisher","unstructured":"Amin M, Scullin K, Nakamura K, Ontaneda D, Galioto R. Cognitive profiles associated with faster thalamic atrophy in multiple sclerosis. Mult Scler Relat Disord Elsevier. 2025;103. https:\/\/doi.org\/10.1016\/j.msard.2025.106662.","DOI":"10.1016\/j.msard.2025.106662"},{"key":"5085_CR12","doi-asserted-by":"publisher","unstructured":"Herron TJ, Kang X, Woods DL. Automated measurement of the human corpus callosum using MRI. Front Neuroinformatics Front. 2012;6. https:\/\/doi.org\/10.3389\/fninf.2012.00025.","DOI":"10.3389\/fninf.2012.00025"},{"key":"5085_CR13","doi-asserted-by":"publisher","first-page":"e37167","DOI":"10.1371\/journal.pone.0037167","volume":"7","author":"S Llufriu","year":"2012","unstructured":"Llufriu S, Blanco Y, Martinez-Heras E, Casanova-Molla J, Gabilondo I, Sepulveda M, et al. Influence of Corpus Callosum Damage on Cognition and Physical Disability in Multiple Sclerosis: A Multimodal Study. PLOS ONE Public Libr Sci. 2012;7:e37167. https:\/\/doi.org\/10.1371\/journal.pone.0037167.","journal-title":"PLOS ONE Public Libr Sci"},{"key":"5085_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.msard.2018.02.003","volume":"21","author":"A Artemiadis","year":"2018","unstructured":"Artemiadis A, Anagnostouli M, Zalonis I, Chairopoulos K, Triantafyllou N. Structural MRI correlates of cognitive function in multiple sclerosis. Mult Scler Relat Disord Elsevier. 2018;21:1\u20138. https:\/\/doi.org\/10.1016\/j.msard.2018.02.003.","journal-title":"Mult Scler Relat Disord Elsevier"},{"key":"5085_CR15","doi-asserted-by":"publisher","unstructured":"Hedderich DM, Schmitz-Koep B, Schuberth M, Schultz V, Schlaeger SJ, Schinz D, et al. Impact of normative brain volume reports on the diagnosis of neurodegenerative dementia disorders in neuroradiology: A real-world, clinical practice study. Front Aging Neurosci Front. 2022;14. https:\/\/doi.org\/10.3389\/fnagi.2022.971863.","DOI":"10.3389\/fnagi.2022.971863"},{"key":"5085_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0895-4356(88)90093-5","volume":"41","author":"LM Nelson","year":"1988","unstructured":"Nelson LM, Franklin GM, Hamman RF, Boteler DL, Baum HM, Burks JS. Referral bias in multiple sclerosis research. J Clin Epidemiol Elsevier. 1988;41:187\u201392. https:\/\/doi.org\/10.1016\/0895-4356(88)90093-5.","journal-title":"J Clin Epidemiol Elsevier"},{"key":"5085_CR17","unstructured":"Roche A, Mar\u00e9chal B, Kober T, Krueger G, Hagmann P, Maeder P et al. Assessing Brain Volumes Using MorphoBox Prototype. Magnetom Flash. Siemens Healthineers; 2017;68. https:\/\/cdn0.scrvt.com\/39b415fb07de4d9656c7b516d8e2d907\/1800000003913239\/f9d95e26c89c\/magnetom-flash-68_assessing-brain-volumes-using-morphobox-prototype_roche_1800000003913239.pdf"},{"key":"5085_CR18","doi-asserted-by":"publisher","unstructured":"Langdon D, Amato M, Boringa J, Brochet B, Foley F, Fredrikson S, Publications Ltd STM et al. 2012;18:891\u20138. https:\/\/doi.org\/10.1177\/1352458511431076","DOI":"10.1177\/1352458511431076"},{"key":"5085_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol Elsevier. 2018;17:162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2.","journal-title":"Lancet Neurol Elsevier"},{"key":"5085_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","volume":"333","author":"World Medical Association","year":"2025","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. JAMA. 2025;333:71\u20134. https:\/\/doi.org\/10.1001\/jama.2024.21972.","journal-title":"JAMA"},{"key":"5085_CR21","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1177\/13524585221127941","volume":"29","author":"LM Hancock","year":"2023","unstructured":"Hancock LM, Galioto R, Samsonov A, Busch RM, Hermann B, Matias-Guiu JA. A proposed new taxonomy of cognitive phenotypes in multiple sclerosis: The International Classification of Cognitive Disorders in MS (IC-CoDiMS). Mult Scler J SAGE Publications Ltd STM. 2023;29:615\u201327. https:\/\/doi.org\/10.1177\/13524585221127941.","journal-title":"Mult Scler J SAGE Publications Ltd STM"},{"key":"5085_CR22","unstructured":"Benedict RHB. Brief Visuospatial Memory Test\u2013Revised: Professional manual. Psychological Assessment Resources; 1997."},{"key":"5085_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1037\/1040-3590.8.2.145","volume-title":"Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity","author":"RHB Benedict","year":"1996","unstructured":"Benedict RHB, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Volume 8. Psychol Assess. US: American Psychological Association; 1996. pp. 145\u201353. https:\/\/doi.org\/10.1037\/1040-3590.8.2.145."},{"key":"5085_CR24","doi-asserted-by":"publisher","unstructured":"Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Publications Ltd STM. 2017;23:721\u201333. https:\/\/doi.org\/10.1177\/1352458517690821.","DOI":"10.1177\/1352458517690821"},{"key":"5085_CR25","unstructured":"Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test\u2013Second Edition (CVLT-II): Adult version manual. The Psychological Corporation; 2000."},{"key":"5085_CR26","unstructured":"Smith A, Helmuth J. The Symbol-Digit Modalities Test: A neuropsychologic test of learning and other cerebral disorders. In: Helmuth J, editor. Learn Disord. Special Child; 1968. pp. 83\u201391."},{"key":"5085_CR27","unstructured":"Smith A. Symbol Digit Modalities Test: Manual. Rev. ed. Western Psychological Services; 1982."},{"key":"5085_CR28","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis. Neurol Wolters Kluwer. 1983;33:1444\u20131444. https:\/\/doi.org\/10.1212\/WNL.33.11.1444.","journal-title":"Neurol Wolters Kluwer"},{"key":"5085_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2377-14-58","volume":"14","author":"S Meyer-Moock","year":"2014","unstructured":"Meyer-Moock S, Feng Y-S, Maeurer M, Dippel F-W, Kohlmann T. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis. BMC Neurol. 2014;14:58. https:\/\/doi.org\/10.1186\/1471-2377-14-58.","journal-title":"BMC Neurol"},{"key":"5085_CR30","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2024. https:\/\/www.R-project.org\/."},{"key":"5085_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1198\/016214504000001907","volume":"100","author":"Y Benjamini","year":"2005","unstructured":"Benjamini Y, Yekutieli D. False Discovery Rate\u2013Adjusted Multiple Confidence Intervals for Selected Parameters. J Am Stat Assoc Taylor Francis. 2005;100:71\u201381. https:\/\/doi.org\/10.1198\/016214504000001907.","journal-title":"J Am Stat Assoc Taylor Francis"},{"key":"5085_CR32","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","volume":"4","author":"AAH de Hond","year":"2022","unstructured":"de Hond AAH, Steyerberg EW, van Calster B. Interpreting area under the receiver operating characteristic curve. Lancet Digit Health Elsevier. 2022;4:e853\u20135. https:\/\/doi.org\/10.1016\/S2589-7500(22)00188-1.","journal-title":"Lancet Digit Health Elsevier"},{"key":"5085_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/aje\/kwac159","volume":"192","author":"M Piccininni","year":"2023","unstructured":"Piccininni M, Rohmann JL, Wechsung M, Logroscino G, Kurth T. Should Cognitive Screening Tests Be Corrected for Age and Education? Insights From a Causal Perspective. Am J Epidemiol. 2023;192:93\u2013101. https:\/\/doi.org\/10.1093\/aje\/kwac159.","journal-title":"Am J Epidemiol"},{"key":"5085_CR34","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.mri.2013.12.012","volume":"32","author":"KA Koenig","year":"2014","unstructured":"Koenig KA, Sakaie KE, Lowe MJ, Lin J, Stone L, Bermel RA, et al. Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis. Magn Reson Imaging. 2014;32:354\u20138. https:\/\/doi.org\/10.1016\/j.mri.2013.12.012.","journal-title":"Magn Reson Imaging"},{"key":"5085_CR35","doi-asserted-by":"publisher","unstructured":"Hsu Y-C, Lieli RP. Inference for ROC Curves Based on Estimated Predictive Indices. arXiv; 2021. https:\/\/doi.org\/10.48550\/arXiv.2112.01772","DOI":"10.48550\/arXiv.2112.01772"},{"key":"5085_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1177\/096228029800700405","volume":"7","author":"NA Obuchowski","year":"1998","unstructured":"Obuchowski NA. Sample size calculations in studies of test accuracy. Stat Methods Med Res SAGE Publications Ltd STM. 1998;7:371\u201392. https:\/\/doi.org\/10.1177\/096228029800700405.","journal-title":"Stat Methods Med Res SAGE Publications Ltd STM"},{"key":"5085_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s41512-021-00116-4","volume":"6","author":"C Sammut-Powell","year":"2022","unstructured":"Sammut-Powell C, Reynard C, Allen J, McDermott J, Braybrook J, Parisi R, et al. Examining the effect of evaluation sample size on the sensitivity and specificity of COVID-19 diagnostic tests in practice: a simulation study. Diagn Progn Res. 2022;6:12. https:\/\/doi.org\/10.1186\/s41512-021-00116-4.","journal-title":"Diagn Progn Res"},{"key":"5085_CR38","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1093\/brain\/awy202","volume":"141","author":"AJC Eijlers","year":"2018","unstructured":"Eijlers AJC, van Geest Q, Dekker I, Steenwijk MD, Meijer KA, Hulst HE, et al. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study. Brain. 2018;141:2605\u201318. https:\/\/doi.org\/10.1093\/brain\/awy202.","journal-title":"Brain"},{"key":"5085_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/NDT.S256689","volume":"17","author":"ES Gromisch","year":"2021","unstructured":"Gromisch ES, Dhari Z. Identifying Early Neuropsychological Indicators of Cognitive Involvement in Multiple Sclerosis. Neuropsychiatr Dis Treat. 2021;17:323\u201337. https:\/\/doi.org\/10.2147\/NDT.S256689.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5085_CR40","doi-asserted-by":"publisher","first-page":"609694","DOI":"10.1155\/2014\/609694","volume":"2014","author":"S Messina","year":"2014","unstructured":"Messina S, Patti F. Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI. Mult Scler Int. 2014;2014:609694. https:\/\/doi.org\/10.1155\/2014\/609694.","journal-title":"Mult Scler Int"},{"key":"5085_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/24709360.2022.2131994","volume":"6","author":"M Mushfiquee","year":"2022","unstructured":"Mushfiquee M, Rahman MS. Propensity score-based adjustment for covariate effects on classification accuracy of bio-marker using ROC curve. Biostat Epidemiol Taylor Francis. 2022;6:292\u2013313. https:\/\/doi.org\/10.1080\/24709360.2022.2131994.","journal-title":"Biostat Epidemiol Taylor Francis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05085-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:52:32Z","timestamp":1787784752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05085-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5085"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05085-z","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Royal Melbourne Hospital Human Research Ethics Committee (QA2021089). All research was conducted in accordance with the ethical standards of the 2024 revision of the Declaration of Helsinki. Consent for the collection, analysis, and publication of the retrospectively obtained and anonymised data for this non-interventional study were waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"544"}}